UBS Asset Management Americas Inc. acquired a new stake in shares of Pharmerica Corporation during the first quarter worth $218,000. (NYSE:PMC) by 14.5% during the first quarter, according to its most recent Form 13F filing with the SEC. 187,459 shares of the company traded hands. California Public Employees Retirement System owned 0.26% of PharMerica worth $1,900,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of PMC.
California Public Employees Retirement System increased its stake in shares of PharMerica Co. JPMorgan Chase & Co. now owns 270,769 shares of the company's stock valued at $6,336,000 after buying an additional 16,613 shares during the period. The value of the investment in Pharmerica Corporation went from $1,900,000 to $2,426,000 a change of 27.7% quarter over quarter. US Bancorp DE boosted its stake in PharMerica by 41.3% in the first quarter. Nuveen Asset Management LLC now owns 863,975 shares of the company's stock valued at $20,217,000 after buying an additional 328,257 shares during the last quarter. Comerica Bank raised its stake in shares of Pharmerica Corporation by 17.1% in the first quarter. Bank of America Corp DE now owns 391,996 shares of the company's stock worth $9,173,000 after buying an additional 146,560 shares in the last quarter. Tudor Investment Corp Et Al purchased a new stake in PharMerica during the fourth quarter valued at $207,000. BlackRock Inc. now owns 3,975,551 shares of the company's stock valued at $93,027,000 after buying an additional 3,967,862 shares during the last quarter. PharMerica has a one year low of $19.20 and a one year high of $29.10.
Warriors star Kevin Durant apologizes for India comments
After returning from his maiden India visit last month, Durant spoke about the trip in an interview with The Athletic website. No offense from this side, I'm coming back out there for more camps and cool s***.
Shares of Pharmerica Corporation (NYSE:PMC) traded down 0.40% during midday trading on Friday, hitting $25.05. Can now owns 45,173 shares of the company's stock valued at $1,052,000 after buying an additional 2,128 shares during the period. The stock has a market cap of $904.07 million, a P/E ratio of 39.36 and a beta of 0.92. The company has a 50-day moving average of $26.64 and a 200-day moving average of $24.94.
PharMerica (NYSE:PMC) last announced its quarterly earnings data on Wednesday, August 2nd. The company reported $0.47 EPS for the quarter, hitting the consensus estimate of $0.47. PharMerica had a net margin of 0.79% and a return on equity of 3.41%. The business had revenue of $592 million for the quarter, compared to analysts' expectations of $592.96 million. Next quarter's EPS is expected be $0.54 and the next full year EPS is anticipated to be $2.17. On average, equities analysts forecast that PharMerica Co. will post $1.92 earnings per share for the current fiscal year. Hedge funds and other institutional investors own 92.84% of the company's stock. If you are viewing this story on another website, it was illegally copied and republished in violation of USA & worldwide copyright and trademark laws. The legal version of this piece of content can be read at https://sportsperspectives.com/2017/08/11/new-york-state-teachers-retirement-system-maintains-stake-in-pharmerica-corporation-nysepmc-updated-updated-updated.html. Credit Suisse Group lowered Pharmerica Corporation from an "outperform" rating to a "neutral" rating and lifted their price objective for the stock from $29.00 to $29.25 in a research report on Friday, August 4th. ValuEngine cut shares of Pharmerica Corporation from a "buy" rating to a "hold" rating in a research report on Friday, June 2nd. Finally, BidaskClub cut shares of Pharmerica Corporation from a "hold" rating to a "sell" rating in a research report on Monday. Finally, Barrington Research cut PharMerica from an "outperform" rating to an "underperform" rating in a research report on Thursday, August 3rd.